As the number of biologics coming to market continues to grow, the demand for drug delivery devices such as the …
Boehringer Ingelheim believes that one of its investigational drugs for liver disease hepatitis C (HCV) could shorten patients’ treatment time …

Roche’s skin cancer pill vismodegib will receive a priority review from the FDA which could see it approved within six …
Visitors to the Priorclave stand 1E02 can evaluate first-hand the benefits of models including:
Novartis has appointed Dr Timothy Wright as the new global head of development of its pharmaceuticals business, effective immediately. Dr …
Nephron earmarks $313m for new US facility, police break up a demonstration at Dr Reddy’s with tear gas, plus updates …
MedImmune’s US manufacturing plant in Frederick, Maryland, has won the 2011 Facility of the Year Award, beating out rival category …
Edge Medical Communications has appointed Dr Laurence De-Netto as account director and Dr Elizabeth Rapley as business development manager. Dr …

Amylin will pay up to $1.6 billion to end its diabetes pact with Lilly after a difficult year for the …
Given the extraordinary costs and risks associated with drug discovery and development, it’s not surprising that an increasing number of …
AstraZeneca and Targacept’s next generation depression drug has failed to meet its primary endpoint in a late-stage trial. The first …
The impacts of NHS reform and the increasingly high cost of R&D is causing pharma to doubt its future in …
Company conferences and events have come a long way since we used to be taken out for a short meeting …
Market access is complicated. Multifaceted, multi-discipline, multidimensional, multi-stake-holder, all these multiples make Market Access one of the most challenging and …
Daniel Grau has been appointed as president of Heptares Therapeutics, a specialist in G-protein-coupled receptors. Mr Grau has been a …

Pfizer will now keep up to 650 jobs at its R&D site in Sandwich, Kent, according to news reports. The …
As a part of the ERA Consultancy Group, European Regulatory Solutions (ERS) specialise in offering consultancy services and regulatory advice …

GlaxoSmithKline has teamed up with gene silencing specialist Alnylam Pharmaceuticals in a project aimed at speeding up the production of …
Bosch Packaging Technology has decided to boost its presence in Asia with the construction of a second plant in the …
No new suitors come forward for PPD, Icon and Charles River report mixed Q3 results, plus updates from Cyprotex and …